Can a simple salt swap keep blood pressure in check?

NCT ID NCT07840742

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting This study
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Sep 25, 2026 · Last updated Sep 25, 2026

Summary

Researchers are testing whether replacing regular table and cooking salt with a low-sodium, potassium-enriched substitute can prevent and control high blood pressure. The trial enrolls entire households that include at least one adult with hypertension and one without. About 400 households take part, with each household randomly assigned to receive either the low-sodium substitute or regular salt for 12 months. Neither the participants nor the researchers know which salt each household receives. The study measures blood pressure changes and new hypertension cases to see if the household approach works.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
A low-sodium salt substitute that replaces some sodium chloride with potassium chloride
What this could lead to
If it works, households could lower their blood pressure by making one simple change to the salt they cook with, without needing extra pills.
What could go wrong
The salt substitute may not lower blood pressure enough to matter, or families may not stick with it for a full year. People with kidney problems or on certain blood pressure medicines should be careful with extra potassium.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

About 800 people

The number the study aims to enrol. It can still change while the study runs.

Expected to start

Oct 2026

An estimate. Start dates often move.

Expected to finish

Dec 2027

An estimate. End dates often move.

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Household-level criteria: The household includes at least one adult aged 18 years or older with diagnosed hypertension. The household includes at least one adult aged 18 years or older without hypertension at baseline. Household members primarily share cooking and meals. All adult household members intended to be included in study evaluations provide written informed consent. -Participant-level criteria: Aged 18 years or older. Long-term resident of the study area with no plan to move away during the following 12 months. Consumes most meals at home. Provides written informed consent. Exclusion Criteria: * Household-level criteria: The household is currently using low-sodium salt or another potassium-containing salt substitute on a long-term basis. Any household member who routinely shares meals has a contraindication to potassium-enriched salt or is at increased risk of hyperkalemia, including chronic kidney disease, estimated glomerular filtration rate (eGFR) \<60 mL/min/1.73 m², a history of dialysis, or a history of hyperkalemia. Any household member who routinely shares meals is pregnant. Any household member who routinely shares meals has hyperthyroidism. -Participant-level criteria: Currently participating in another interventional study that may affect blood pressure, sodium or potassium intake, or study outcomes. Serious cardiovascular or cerebrovascular disease, severe liver disease, malignant tumor, severe mental illness, cognitive impairment, or another condition considered unsuitable for study participation. Unable to complete follow-up visits, standardized blood pressure measurements, or required data collection. Any other condition that, in the investigator's judgment, makes the individual unsuitable for participation.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Hypertension are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

How to take part

Only the study team decides who joins. These are the ways to reach them.

  1. The places running it

    1 site. The list below names each one and where it is.

  2. The official record

    ClinicalTrials.gov lists the study team's own contact details, including names and phone numbers. We don't republish those.

    Open the record ↗

  3. A doctor treating you

    A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.

Contacts and locations

Locations

  • Shihezi City People's Hospital

    Shihezi, Xinjiang, 832000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.